Ruxolitinib in treatment-naive or corticosteroid-refractory paediatric patients with chronic graft-versus-host disease (REACH5): interim analysis of a single-arm, multicentre, phase 2 study

Franco Locatelli, Cristina Díaz de Heredia, Hyoung Jin Kang et al.|The Lancet Haematology|2024

Cited by 18